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ProtozoaThe ubiquitous Hsp90 is critical for protein homeostasis in the cells, stabilizing “client” proteins in a functional
state. Hsp90 activity depends on its ability to bind and hydrolyze ATP, involving various conformational changes
that are regulated by co-chaperones, posttranslational modiﬁcations and small molecules. Compounds like
geldanamycin (GA) and radicicol inhibit the Hsp90 ATPase activity by occupying the ATP binding site, which
can lead client protein to degradation and also inhibit cell growth and differentiation in protozoan parasites.
Our goal was to produce the recombinant Hsp90 of Leishmania braziliensis (LbHsp90) and construct of its
N-terminal (LbHsp90N) andN-domain andmiddle-domain (LbHsp90NM),which lacks the C-terminal dimeriza-
tion domain, in order to understand how Hsp90 works in protozoa. The recombinant proteins were produced
folded as attested by spectroscopy experiments. Hydrodynamic experiments revealed that LbHsp90N and
LbHsp90NM behaved as elongated monomers while LbHsp90 is an elongated dimer. All proteins prevented
the in vitro citrate synthase and malate dehydrogenase aggregation, attesting that they have chaperone activity,
and interacted with adenosine ligands with similar dissociation constants. The LbHsp90 has low ATPase activity
(kcat=0.320 min−1) in agreement with Hsp90 orthologs, whereas the LbHsp90NM has negligible activity,
suggesting the importance of the dimeric protein for this activity. The GA interacts with LbHsp90 andwith its do-
main constructions with different afﬁnities and also inhibits the LbHsp90 ATPase activity with an IC50 of 0.7 μM.
All these results shed light on the LbHsp90 activity and are the ﬁrst step to understanding the Hsp90 molecular
chaperone system in L. braziliensis.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
The parasitic disease called Leishmaniasis is caused by protozoa of
the genus Leishmania. It is one of the so-called “neglected diseases”
that afﬂictsmainly people of poor countries [1,2] and remains an impor-
tant challenge to health care including the need to develop new drugs
for more effective treatments [3]. In this context, molecular chaperones
have been indicated as a target for drug development against protozoa
[4–7] since they are essential for protein metabolism [8]. Molecular
chaperones of the family Hsp90 (heat shock proteins of 90 kDa) are
present in almost all organisms, reaching 1–2% of total cytoplasmic sol-
uble proteins (reviewed in [9–11]). Therefore, we are studyingmolecu-
lar chaperones of Leishmania braziliensis in order to understand how
these proteins work in protozoa.D, circular dichroism; ƒ/ƒ0, fric-
Stokes radius for a smooth and
sedimentation coefﬁcient at
fﬁcient at 0 mg/mL of protein;
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ão Carlos, Universidade de São
s, SP, Brazil. Tel.: +55 16 3373
 OA license.Hsp90 forms ﬂexible homodimers in which each protomer can
be divided into three domains: the N-terminal (N-domain), the Middle-
segment (M-domain), and the C-terminal (C-domain) (reviewed in
[9–11]). The N-domain (~25 kDa) contains an ATP binding site impor-
tant for Hsp90 functioning in vivo, since it presents ATPase activity that
depends on N-domain dimerization [11–15]. Moreover, the N-domain
can also interact with substrates and co-chaperones [9,11,15,16]. The
N-domain is connected to the M-domain by a charged segment of var-
iable length (linker) [9,11,17] that is implicated in N-domain dimeriza-
tion and ATPase activity regulation [18]. The M-domain (~35 kDa) has
multiple sites for client proteins and co-chaperones, and two conserved
residues (Arg380 and Gln384 related to yeast Hsp90–yHsp90) that
form a plastic catalytic loop essential for the N-domain ATPase activity
by interacting with γ-phosphate from the ATP bound in the nucleotide
binding site [11,19,20]. The C-domain (~20 kDa) is responsible for
Hsp90 dimerization [21,22], and possesses residues that are impor-
tant for interaction with substrate, and for interaction with TPR
(tetratricopeptide repeat) based co-chaperones [10,11].
The Hsp90 function depends on its lowATPase activity that is tightly
regulated by interactionwith a plethora of co-chaperones, by N-domain
dimerization and amino acids along its own sequence, and involves
conformational changes that interfere with the ATP hydrolysis rate
[11,13,15–17,19,22–25]. The conformational changes needed for ATP
hydrolysis are triggered by ATP binding in the N-domain, in the open
state of Hsp90, leading to intermediate states and then to the closed
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with the M-domain result in ATP hydrolysis [9,11,15,19,23,25]. Recent-
ly, it was shown that yHsp90 cycle is not strikingly dependent on ATP
binding, since it exists, in solution, in several conformational states depen-
dent on temperature suggesting that they are thermally driven [26,27].
During Hsp90 mechanism cycle, diverse substrates (namely steroid hor-
mone receptors, kinases, and unrelated substrates), co-chaperones and
other molecular chaperones may associate with Hsp90, forming dy-
namic heterocomplexes [10,11,20,28]. Although the Hsp90's molecular
mechanism seems to be conserved, slight regulatory differences that
occur across species (such as co-chaperone repertoire, posttranslational
modiﬁcations, small molecules and even client binding) have been
reported, hence suggesting that Hsp90 has species-speciﬁc regulations
[9–11,17,18].
It has been reported that interference with the functional cycle of
Hsp90, either by mutations or inhibitors, can lead to cell death. Sever-
al Hsp90 inhibitors have been described in the literature, including
GA (and analogues) and radicicol, which bind at the nucleotide bind-
ing site in the N-domain in order to mimic the ATP [12,13,15,29]. The
Hsp90–GA interaction leads to degradation of misfolded client proteins
via the ubiquitin-proteasome system [11,28,30]. Hsp90 is considered a
promising target to combat certain types of cancers because of its im-
portance for the maturation of oncoproteins [11,31,32].
Moreover, Hsp90 has been investigated as a possible target for the
treatment of protozoa diseases such those caused by Plasmodium
falciparum, Trypanosoma cruzi and Leishmania donovani, where the
Hsp90 inhibition by GA led to defects in cell growth and differentiation
[5,33–36]. In this context, it is relevant to understand the structure–
function relationship of Hsp90 of L. braziliensis (LbHsp90/Hsp83-1) in
order to identify its particularities related to its functional cycle and in-
hibition. Here, we present the overall functional and structural charac-
terization of the LbHsp90 as the ﬁrst step for further studies on the
protozoa Hsp90 molecular chaperone system.
2. Material and methods
2.1. Sequence analysis
The sequence identity among LbHsp90/Hsp83-1 (GenPept ID:
XP_001567804.1 — GENE ID: 5418737 LBRM_33_0340) and the well
characterized orthologous Hsp90 of Leishmania major (LmHsp90 —
GenPept ID: XP_001685759.1), L. donovani (LdHsp90 — GenPept ID:
ADX97246.1), T. cruzi (TcHsp90 — GenPept ID: XP_811791.1),
Trypanosoma brucei (TbHsp90 — GenPept ID: XP_823307.1), yHsp90
(GenPept ID: NP_015084.1) and human (hHsp90α — GenPept ID:
NP_005339.3) were analyzed using the Clustal W program (http://
www.ebi.ac.uk/Tools/msa/clustalw2/).
2.2. Cloning, expression and puriﬁcation
The coding DNA for LbHsp90 was ampliﬁed by PCR using the fol-
lowing primers: 5′‐AATCATATGACGGAGACGTTCGCG-3′ and 5′-GGC
GGAATTCAGTCCACCTGCTCCATG-3′ containing restriction sites for
Nde I and Eco RI, respectively. The DNA of LbHsp90 was cloned into
the pET28a (Novagen) expression vector, generating the recombi-
nant plasmid pET28a::LbHsp90. The cloning of LbHsp90 N-domain
(LbHsp901–221–LbHsp90N) and LbHsp90 NM-domains (LbHsp901–522–
LbHsp90NM) into pET28a expression vector were made follow-
ing the same procedure using the following antisense primers
5′-TCTTCGGCGGATCCTACTCCTCGTCC-3′ and 5′-AAGTGAGCTCATTCCTT
CGTCAGGCAC-3′, which inserted restriction sites for Bam HI and
Sac I, respectively. All recombinant plasmids were checked by
DNA sequencing.
The protein expression was performed using the Escherichia coli
BL21(DE3) strain where the bacterial culture was grown at 37 °C
and 200 rpm up to OD600 0.4–0.6, the temperature was decreased to30 °C and the protein expression was induced by the addition of
0.4 mM of IPTG, for 4 h at 200 rpm. The cells were harvested by cen-
trifugation, resuspended in the buffer 50 mM Tris–HCl (pH 8.0),
100 mM KCl and incubated on ice for 30 min after the addition of
30 μg/mL lysozyme (Sigma) and 5 U DNase (Promega). The lysis of
the bacterial cells was performed by sonication, followed by centri-
fugation and ﬁltration of the supernatant in a 0.45 μm membrane.
The ﬁrst step of LbHsp90 puriﬁcation and its domain constructions
was performed by an afﬁnity chromatography using a HisTrap column
(GE Life Sciences). The second step of the puriﬁcation was performed
by a size exclusion chromatography (SEC) using the Superdex 200
16/60 column (GE Life Sciences) previously equilibrated with the
40 mM HEPES buffer (pH 7.5), KCl 100 mM. Both steps were carried
out with columns coupled to an ÄKTA Prime device (GE Life Sci-
ences) and the protein elution proﬁles were monitored by absor-
bance at 280 nm. The efﬁcacy of each puriﬁcation step was checked
by 12% SDS-PAGE. The His-tag of LbHsp90Nwas cleaved by the incuba-
tion of 10–15 mgof the target proteinwith 1 U of thrombin (Sigma) for
48 h at 4 °C. The concentrations of the puriﬁed proteins were deter-
mined spectroscopically using the molar extinction coefﬁcient (ε) pre-
dicted by the amino acid sequence.
2.3. Spectroscopy studies
Circular dichroism (CD) measurements were performed in a Jasco
J-810 spectropolarimetric device coupled to a Peltier-type temperature
control system PFD 425S. The LbHsp90 CD spectra were measured in a
0.2 mm circular cuvette containing 0.55 mg/mL of protein in the buffer
40 mMHEPES (pH7.5), 100 mMKCl in the presence or absence of 5 mM
MgCl2. The scanning rate used for spectra collection was 100 nm/min
with spectral bandwidth of 1 nm. The CD spectra were normalized to
mean residue molar ellipticity ([θ]) and the protein secondary structure
content was predicted using the CDNNDeconvolution program [37]. The
same procedures were performed for 0.25 mg/mL of LbHsp90Nwith the
His-tag cleaved and 0.30 mg/mL of LbHsp90NM in the same buffer of the
LbHsp90 and using a 1 mm pathlength cell.
The intrinsic ﬂuorescence emission experiments were performed in
an F-4500ﬂuorescence spectrophotometer (Hitachi), using a 10×2mm
pathlength cell. The samples were excited at 280 nm and the intrinsic
ﬂuorescence emission spectra were collected from 290 nm to 420 nm.
The protein concentrations used were of 2.5 μM prepared in 40 mM
HEPES (pH 7.5), containing 100 mM KCl. The effect of the polar aprotic
solvent dimethyl sulfoxide (DMSO) on the LbHsp90 structure was de-
termined by analyzing the intrinsic ﬂuorescence emission in the con-
centration range of 0–5% V/V.
The intrinsic ﬂuorescence emission data were analyzed by their
maximum emission wavelength (λmax) and spectral center of mass
(bλ>) as described by the equation below:
bλ >¼ ΣFiλi=ΣFi ð1Þ
where λi is the wavelength measures and Fi is the ﬂuorescence inten-
sity at λi.
2.4. Hydrodynamic experiments
Analytical SEC experiments were carried out using a Superdex
200 10/300 GL column (GE Healthcare), coupled to an ÄKTA Puriﬁer
device (GE Healthcare) and equilibratedwith the 25 mMTris–HCl buff-
er (pH 7.5), 100 mM NaCl and 5 mM β-mercaptoethanol. Aliquots of
100 μL of protein (12.5–25 μM) were loaded into the column at a ﬂow
rate of 0.5 mL/min and the elution proﬁlewasmonitored by absorbance
at 280 nm. The columnwas previously calibratedwith amix of standard
proteins with known Stokes radii (Rs): apoferritin (67 Å); γ-globulin
(48 Å), bovine serum albumin (36 Å), ovalbumin (30 Å) and carbonic
anhydrase (24 Å). All standard proteins (Sigma) were prepared at
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the column was determined using blue dextran 1 mg/mL (Sigma).
The retention volume measured for the proteins was converted in
the partition coefﬁcient (kav) by the following equation:
kav ¼ Ve−V0=Vt−V0 ð2Þ
where Ve is the retention volume of the protein; V0 is the void vol-
ume of the column and Vt is the total volume of the column. The Rs
of the standard proteins was plotted against the −(log Kav)1/2 and
the curve was adjusted by linear ﬁtting analysis. The ﬁtting parame-
ters were applied to calculate the Rs for LbHsp90, LbHsp90N and
LbHsp90NM.
The dissociation constant (KD) for LbHsp90 dimer dissociation into
monomers was determined by analytical SEC as shown in [22]. Thus,
100 μL of LbHsp90 in the concentration range of 125 nM to 12.5 μM
solved in 40 mM HEPES (pH 7.5) containing 100 mM KCl was loaded
onto a Superdex 200 10/300 GL column coupled to an ÄKTA Puriﬁer
device (GE Healthcare). The elution times (ET), monitored by absor-
bance at 280 nm, were plotted as a function of protein concentration
with the assumption of a dilution factor of 7 times [22]. The dissocia-
tion curve was ﬁtted by the following equation:
ET ¼ ETmon− ETmon−ETdimð Þ
Protein½ 
KD þ Protein½ 
ð3Þ
where ETmon is the elution time of the monomeric species, and ETdim
is the elution time of the dimeric species.
Analytical ultracentrifugation (AUC) experiments were carried out
in a BeckmanOptimaXL-A analytical ultracentrifuge. Sedimentation ve-
locity (SV) experiments for LbHsp90,were carried out in concentrations
ranging from 0.15 to 1.0 mg/mL in 25 mM Tris–HCl (pH 7.5), 50 mM
NaCl, 1 mM β-mercaptoethanol, at 20 °C, 25,000 rpm (AN-60Ti rotor),
and data acquisition at 236 nm or 239 nm, depending on the sample
concentration. AUC experiments with LbHsp90NM were performed at
35,000 rpm (AN-60Ti rotor), 20 °C in concentrations ranging from
0.15 to 1.0 mg/mL in 25 mM Tris–HCl (pH 7.5), 50 mM NaCl, 1 mM
β-mercaptoethanol and the data acquisition was done at 276 nm. The
experimental absorbance versus cell radius data was ﬁtted by the SedFit
software (Version 12.1), which numerically solves the Fredholm type
integral equation to calculate the distribution function of sedimentation
coefﬁcients c(S) [38]. The frictional ratio (ƒ/ƒ0) parameter was allowed
to ﬂoat freely and worked as a regularization parameter for the ﬁtting
equation. The experimental sedimentation coefﬁcients (s) were found
as the maximum of the peaks of the c(S) curves. The experimental
s-value contains interferences caused by buffer density and viscosity,
and by temperature, thuswe calculated the standard sedimentation co-
efﬁcient at 0 mg/mL of protein concentration (s020,w), which is an
intrinsic parameter of the particle [39]. The SedFit software esti-
mated the standard sedimentation coefﬁcients (s20,w) since we
supplied the buffer viscosity (η=1.0142×10−2 poise), buffer density
(ρ=1.00101 g/mL) and partial-speciﬁc volume of each protein studied
here (Vbar: LbHsp90=0.7342 mL/g; LbHsp90NM=0.7353 mL/g), which
were estimated by the Sednterp program (www.jphilo.mailway.com/
download.htm). The s020,w was estimated by linear regression of the
curve of s20,w-value as a function of the protein concentration. The ƒ/ƒ0
can also be estimated by the ratio of the experimental Rs to the radius
of a sphere of the same MM, or by the ratio of the sedimentation coefﬁ-
cient of a sphere of the same mass to the experimental one [40].
2.5. Interaction with ligands
The LbHsp90 ligand interaction was investigated by suppression
of the intrinsic ﬂuorescence emission [5,41]. The measurements
were performed in an F-4500 Fluorescence Spectrophotometerdevice (Hitachi), using a 10×2 mm pathlength cuvette. Samples were
excited at 280 nm and ﬂuorescence emission spectra were collected
from 290 nm to 420 nm. The LbHsp90 at 2.5 μM was incubated for
30 min, at 20 °C, with ligands (ATP, ADP, AMPPNP) at concentrations
ranging from 0 to 750 μM in 40 mM HEPES (pH 7.5), 100 mM KCl, in
the presence or absence of MgCl2. For LbHsp90–GA interaction, the pro-
tein concentration used was 2 μM with concentrations of GA varying
from 0 to 50 μM in the same buffer described above in the presence of
DMSO 1%. The stock solution of GA (10 mM) was prepared into DMSO
100%. The data collected were treated for inner ﬁlter effects [42], as de-
scribed by the equation below:
F ¼ Fu exp−2:303εIL0 ð4Þ
where F is the corrected ﬂuorescence, Fu is the experimental ﬂuores-
cence, ε is the molar extinction coefﬁcient of the ligand in 280 nm, I is
the pathlength and L0 is the ligand concentration. Interaction experi-
ments with GA were corrected by the GA absorbance at both 280 nm
and 330 nm, using a similar equation. The ε of the ligands was calculat-
ed, in the buffer described above and at the wavelength tested, by the
slope of the curve of absorbance versus the ligand concentration.
With the corrected ﬂuorescence values, a graph of F0−F / Imax was
constructed (where F0 and F are the corrected ﬂuorescence intensities
in the absence and in the presence of a given concentration of ligand,
respectively, Imax is the maximum ﬂuorescence intensity) as a func-
tion of the ligand concentration ([L]). The curves were ﬁtted with
the one independent site binding model (Origin software) generating
the value of the KD, as described by the following equation:
F0−F=Imax ¼ L½ = L½  þ KD: ð5Þ
The same protocol was used for the ligand interaction analysis
with the LbHsp90N and LbHsp90NM.
2.6. Hsp90 chaperone activity
The chaperone activities of LbHsp90, LbHsp90NM and LbHsp90N
were tested analyzing their ability to prevent protein aggregation.
The samples containing citrate synthase (CS) at 0.8 μM or malate dehy-
drogenase (MDH) at 1 μM in the absence and presence of LbHsp90,
LbHsp90NM or LbHsp90N, at increasing concentrations, were incubated
for 1 h at 45 °C or 40 °C, for CS and MDH samples, respectively, in
40 mM HEPES (pH 7.5) [43]. The protein aggregation was followed by
light scattering at 320 nm using a V-630 spectrophotometer (Jasco)
coupled to a temperature control system. As control experiments, the
CS at 0.8 μM was incubated at 45 °C with bovine serum albumin
(BSA) at 0.8 μM. The aggregation propensity of LbHsp90, LbHsp90N
and LbHsp90NM was also tested at the described temperatures for
60 min.
2.7. ATPase activity
The EnzChek® Phosphate Assay Kit (Invitrogen) was used to investi-
gate the LbHsp90 ATPase activity [22]. The kit provides amethod for the
quantization of inorganic phosphate (Pi) in solution. The Pi released is
related to ATP hydrolysis by LbHsp90, and it can bemeasured according
to a standard curve containing Pi in the range of 10 up to 100 μM. The
LbHsp90 (2 μM; monomer concentration), was suspended in 40 mM
HEPES (pH 7.5) containing 100 mM KCl and 5 mM MgCl2, in the pres-
ence of ATP (0 to 5 mM) for 90 min at 37 °C. The negative control
was represented by ATP alone. The samples containing the Pi hydro-
lyzed from ATP were incubated with 0.2 U of purine nucleoside phos-
phorylase (PNP) and 0.2 μM of MESG, a chromogenic substrate. After
30 min of incubation of the solution with PNP and MESG at 23 °C, the
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minute (i.e. V0 in μM/min) was plotted as a function of the ATP concen-
tration (mM), and aMichaelis–Menten ﬁttingwas applied to obtain the
kinetic parameters using the Origin software. The LbHsp90NM ATPase
activity was investigated as described for LbHsp90.
2.8. ATPase activity inhibition
Geldanamycin was tested as an inhibitor of the LbHsp90 ATPase
activity, using the experiment depicted in the previous section. For
that, LbHsp90 (1 μM — monomer concentration) was incubated with
GA (0 at 25 μM) for 30 min at room temperature, then ATP (3 mM)
was added to the samples and submitted at 37 °C for 3 h. The assay
was performed in the presence of 5 mMMgCl2, and the DMSO concen-
tration was ﬁxed at 2% (v/v). A negative control was set up for each
sample, and the data were ﬁtted with a dose–response function in
order to obtain the 50% inhibitory concentration value (IC50).
3. Results and discussion
3.1. Sequence analysis, expression and puriﬁcation
The genome of L. braziliensis has 5 annotated genes for Hsp90 pro-
teins. Here, we describe the cytoplasmatic Hsp90, which is also named
Hsp83-1 and is encoded by the chromosome 33 (GENE ID: 5418737
LBRM_33_0340). Two other putative genes encoding Hsp90 were also
identiﬁed on the genome: GENE ID: 5418970 LBRM_33_2670 and
GENE ID: 5417310 LBRM_29_0780, which share 30% identity and 40%
identity with LbHsp90, respectively. Interestingly, two other genes
(GENE ID: 5418738 HSP83-1 and GENE ID: 5418736 HSP83-1) encoding
putative proteins 99% identical to the C-terminal half sequence of
LbHsp90 were also identiﬁed. A BLAST search against L. braziliensis ge-
nome also indicated several DNA sequences in the chromosome 33
that has high identity with LbHsp90. These putative genes and DNA se-
quences should be products of gene duplication events.
The LbHsp90 amino acid sequencewas analyzed in comparisonwith
the L. major, L. donovani, T. cruzi, T. brucei, yeast and human orthologs.
The sequence alignment showed a high level of conservation and
LbHsp90 presented around 93% of identity with the Hsp90 proteins
of L. major and L. donovani; around 85% of identity with the T. cruzi
and T. brucei orthologs; and 63% of identity with both hHsp90 and
yHsp90 (Fig. 1A). The N-domain of yHsp90 exhibits the D79 amino
acid residue (D93 in the hHsp90α), a key residue for ATP and inhibitor
binding (such as GA and radicicol), located in the inner region of
the ATP binding pocket [12–14,29]. In addition, the E47 residue is criti-
cal for the nucleotide hydrolysis in hHsp90 [14]. The charged linker of
LbHsp90 and of other trypanosomatids Hsp90 is smaller than in both
yHsp90 and hHsp90α, suggesting that trypanosomatids Hsp90 could
present slight differences in the ATPase activity, since the length
of the charged linker inﬂuences this activity, as previously shown
[11,17,18].
In the M-domain, the R380 and Q384 residues are critical for
the yHsp90 ATPase activity by orienting the γ-phosphate of the
ATP; mutations in these residues cause loss of function [19]. The
F349 residue also seems to be important for N- and M-domains
intercommunication, since it participates by orienting the catalytic
groups, mutations in this residue impair the v-Src activation and de-
crease the Hsp90 ATPase activity [19]. Lastly, the yHsp90 and client
protein interaction appears to involve the W300 residue [19,20].
Comparing the seven sequences analyzed in Fig. 1A, all these amino
acid residues are conserved, suggesting that the mechanisms of ATP
binding and hydrolysis for LbHsp90 and of other trypanosomatids,
as well as the structural characteristics, could be similar to those ob-
served for both yHsp90 and hHsp90.
The hHsp90α, the constitutive human cytoplasmic protein, shows
59% and 63% of amino acid sequence identity with the Hsp90 fromP. falciparum and L. braziliensis, respectively. The ATP and GA bind-
ing site of the protozoa proteins are very similar to hHsp90α, except
for two amino acids (Ala37 to Ser52 and Lys72 to Arg87— Fig. 1A, stars).
It is interesting to note that despite the amino acid sequence similarity
between Hsp90 proteins, inhibitors that interact selectively with differ-
ent isoforms have been reported across various species [31] suggesting
the presence of structural species speciﬁc characteristics on the nucleo-
tide binding site [9–11,17,18].
The evolutionary conservation among trypanosomatids Hsp90,
yHsp90 and hHsp90 can be represented by the tryptophan residues in
their amino acid sequences. Almost all tryptophan residues were con-
served along their amino acid sequences (Fig. 1A, inside boxes). The ex-
ception is found in hHsp90 which presents a Y381, while this position is
occupied by a W in Hsp90 of trypanosomatids and yHsp90. Fig. 1B and
C present the environment of the tryptophan residues in the crystallo-
graphic structures deposited in the Protein Data Bank (PDB) for the
N-domain (PDB ID: 3U67) and M-domain and C-domain (PDB ID: 3HJC)
of LmHsp90. The LmHsp90 structures revealed that W147 is buried in
the protein structure, whereas W269, W292, W353 and W578 seem
to be exposed or partially exposed to the solvent. The W147 residue,
located in the N-domain of LbHsp90 close to the ATP binding pocket,
as a probe was used to investigate the interaction with the ligands
(see below — Fig. 1).
In order to study the structure and function of LbHsp90, we
cloned its DNA and other two constructs contained the N-domain
and the NM-domains of the LbHsp90 into the pET28a expression
vector to produce the recombinant proteins LbHsp90, LbHsp90N
(LbHsp901–221) and LbHsp90NM (LbHsp901–522). The recombinant
proteins were profusely expressed by E. coli BL21(DE3) strain in
the soluble fraction of the bacterial lysate (Fig. 2A — lanes 2, 6 and
10). The puriﬁcation of the recombinant proteins was performed by
immobilized metal ion afﬁnity (Fig. 2A— lanes 3, 7 and 11) followed
by a preparative SEC (Fig. 2A — lanes 4, 8 and 12). The ﬁnal purity was
higher than 95%, as attested by SDS-PAGE (Fig. 2A). For LbHsp90N, after
the afﬁnity chromatography, the His-tag was cleaved by incubation
with thrombin (Fig. 2A — lane 12).
3.2. Spectroscopic studies
To access information about the secondary and tertiary structures of
LbHsp90 and its domains, and if the proteinswere produced folded, cir-
cular dichroism and intrinsic ﬂuorescence emission experiments were
performed. The circular dichroism spectra of the proteins showed that
they were obtained folded and suggested that they exhibit some struc-
tural elements characteristic for α-helix and β-sheet proteins (Fig. 2B).
Furthermore, the addition of MgCl2 into LbHsp90 solution does not
seem to induce changes in the secondary structure of the protein
(data not shown). The spectra deconvolution and secondary structure
prediction were done using the CDNN Deconvolution program and
the results are shown in Table 1. The content of α-helix structure esti-
mated for LbHsp90 was about 35%, a value in good agreement to
those observed in Hsp90 orthologs that have structural information
available (see Fig. 1B) [12,16,19,44].
The local tertiary structure was investigated using the intrinsic ﬂuo-
rescence properties of the tryptophan residues found in the proteins.
Fig. 2C shows the intrinsic ﬂuorescence emission spectra of LbHsp90
and its domains and Table 1 shows the values of the λmax and bλ>.
For LbHsp90N, the values for λmax and bλ> were 311±1 nm and
323±1 nm, respectively, which indicate that the single tryptophan res-
idue of the N-domain of LbHsp90 is buried in the protein structure. The
LbHsp90NM presented a λmax-value of 319±1 nm and a bλ> of
335 nm. Since the ﬂuorescence emission spectra are an average of the
contribution of all tryptophan residues distributed along the protein
and as the tryptophan ﬂuorescence spectrum is dependent on the po-
larity of the environment [45], the changes observed in the λmax and
bλ> values for the LbHsp90NM could be related to contributions of
Fig. 1. Sequence alignment analysis of LbHsp90. A) The amino acid sequences of LbHsp90, LmHsp90, LdHsp90, TcHsp90, TbHsp90, hHsp90α and yHsp90were aligned and revealed an iden-
tity of 93% between the LbHsp90 and both LmHsp90 and LdHsp90; 85% with TcHsp90 and TbHsp90; and 63% with hHsp90 and yHsp90. The conserved amino acid residues involved in ATP
binding andhydrolysis (discussed in Section 3.1.) are indicated by black arrows; the tryptophan residues outlined by rectangles; and the differential residues in theATPbinding pocket among
hHsp90α and Hsp90 from P. falciparum and L. braziliensis are indicated by stars. Conservation between identical amino acid residues (*), residues with strongly similar properties (:) and
weakly similar properties (.) are represented. B) Crystal structures of the LmHsp90 N-domain ADP-bound (PDB ID: 3U67) and the LmHsp90 M-domain and C-domain (PDB ID: 3HJC)
showing the tryptophan residues and the ADP.
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exposed to the solvent, as observed in the LmHsp90 structure. For
LbHsp90, the additional changes are related to the W581 residue lo-
cated in the C-domain of the protein. These data corroborate with the
models presented above regarding the localization of the tryptophanresidues along the protein structure of different organisms and the
high level of conservation observed for the Hsp90 domains, mainly
the N-domain.
In summary, circular dichroism and intrinsic ﬂuorescence emis-
sion data showed that LbHsp90, LbHsp90NM and LbHsp90N were
Fig. 2. Obtainment and spectroscopic analysis of the LbHsp90, LbHsp90N and
LbHsp90NM. A) The LbHsp90 (right), LbHsp90NM (middle) and LbHsp90N (left) pro-
teins are indicated by arrowheads. MM: molecular mass markers; lanes 1, 5 and 9:
cell lysate before induction; lanes 2, 6 and 10: cell lysate after induction; lanes 3, 7
and 11: proteins eluted from afﬁnity chromatography; lanes 4, 8 and 12: proteins
after the SEC. The N-terminal His-tag of the LbHsp90N was cleaved by thrombin.
The protein puriﬁcation yielded proteins with purity higher than 95%. B) Circular di-
chroism spectra of LbHsp90 (ﬁlled black squares), LbHsp90NM (empty triangles) and
LbHsp90N (empty circles) were acquired in the buffer 40 mM HEPES (pH 7.5),
100 mM KCl, and the data were normalized for mean molar residual ellipticity.
These results suggested that LbHsp90 and its domains are comprehended by α-helix
and β-sheet conformation, according to the data generated by CDNN deconvolution
(Table 1). C) LbHsp90 (solid line), LbHsp90NM (dash-dotted line) and LbHsp90N (dashed
line) intrinsic ﬂuorescence emission spectra were obtained exciting the samples at
280 nmand collecting theﬂuorescence emission from290 nmup to 420 nm, in the buffer
40 mMHEPES (pH 7.5), KCl 100 mM. The ﬂuorescence spectra reﬂect the tryptophan res-
idue environment and showed that LbHsp90 and either LbHsp90NM and LbHsp90N
presented tertiary structure.
Table 1
Summary of LbHsp90 structural features from spectroscopic and hydrodynamic data.
Technique Property Protein
LbHsp90a LbHsp90NMb LbHsp90Nb
cCD α-Helix (%) 35±2 26±2 34±2
β-Sheet (%) 16±1 22±1 17±1
β-Turn (%) 20±1 18±1 17±1
Random coil
(%)
30±2 33±2 31±2
Fluorescence λmax (nm) 331±1 319±1 311±1
bλ>(nm) 338±1 335±1 323±1
Predicted hydrodynamic
data
MMpredd
(kDa)
164 62 26
R0d (Å) 36 26 19
Analytical SEC Rs (Å) 59±2 36±2 26±2
ƒ/ƒ0e 1.6±0.1 1.4±0.1 1.3±0.1
AUC s020,w (S) 5.96±
0.06
3.91±0.02 ND
ƒ/ƒ0f 1.72±
0.06
1.5±0.1 ND
MMexp (kDa) 162±3 66±1 ND
ND: not determined.
a Predicted R0 and MMpred data as dimer.
b Predicted R0 and MMpred as monomer.
c Secondary structure generated by deconvolution of the experimental CD spectra
using the CDNN Deconvolution program.
d Predicted from the amino acid composition by the Sednterp program.
e From the ratio of Rs by R0.
f Obtained from SedFit analysis.
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structure that is similar to those of Hsp90 proteins.
3.3. Hydrodynamic characterization
The ﬁrst step of hydrodynamic characterization of LbHsp90 and
its domains was performed by analytical SEC. This technique was
used to get access of the hydrodynamic properties of the proteins
studied, such as Rs and protein shape. From the volume of retention
of LbHsp90, LbHsp90NM and LbHsp90N, and utilizing standard pro-
teins with known Stokes radii, the Rs and ƒ/ƒ0 of those proteins could
be estimated. Fig. 3A depicts the elution proﬁle of the proteins allowing
the comparison with the elution proﬁle of the standard protein mix
(see Section 2.4.). The data analysis yielded the results shown in
Table 1 pointing that LbHsp90 eluted with a Rs of around 59 Å, which
is equivalent to a globular protein of about 300 kDa, suggesting that
LbHsp90 could be a tetramer. The ƒ/ƒ0 of LbHsp90 as a dimer, like the
Hsp90 orthologs [16,21], calculated by the ratio of the experimental Rs
for the predicted Rs of a globular protein of 162 kDa (R0), was 1.6
suggesting that it is an elongated dimer. Further investigation of the olig-
omeric state and shape of Lbhsp90 was performed by sedimentation ve-
locity AUC technique. The LbHsp90 sediments as a single species with
s020,w and MM of 5.96±0.06 S and 162±3 kDa, respectively, suggest
that it behaves as a dimer (Fig. 3B; Table 1). AUC data also indicated
that LbHsp90 exhibit a ƒ/ƒ0 of 1.72±0.06, suggesting it has a high elon-
gated shape.
The Rs determined by SEC experiments for LbHsp90N and
LbHsp90NM were slightly higher than those calculated for globular
monomers (Table 1), suggesting that these proteins behaved as slightly
elongated monomers in solution. Sedimentation velocity experiments
with LbHsp90NM (Fig. 3B; Table 1) revealed that this construction be-
haves as a monomer with s020,w of 3.91±0.02 S and MM of 66±
1 kDa. The ƒ/ƒ0 observed for LbHsp90NM was 1.5±0.1, conﬁrming it
has a slight elongated shape. These hydrodynamic results were expected
since both LbHsp90N and LbHsp90NMdid not have the C-domain that is
responsible for Hsp90 dimerization [21,22].
It is well known that yHsp90 dissociates into monomers presenting
KD of around 60 nM, allowing one obtaining “asymmetric” dimers
formed by mutated and wild type protomers, for instance [22]. Besides
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mechanism [26], suggesting the importance of this determination for
Hsp90s. We investigated the LbHsp90 dissociation by means of analyt-
ical SEC where the elution proﬁle of the protein changed and separated
into two peaks as well as the protein concentration decreased (Fig. 3C).
By application of Eq. 3 (seeMaterial andmethods for details), we deter-
mined the KD of LbHsp90 into monomers of 80±10 nM (Fig. 3C, inset),
which is in the same range value of yHsp90 [22].Fig. 3. Investigation of the hydrodynamic properties of LbHsp90 and its domains. A) Ana-
lytical SEC experiments were performed in the buffer 25 mM Tris–HCl (pH 7.5), 100 mM
NaCl, 5 mM β-mercaptoethanol using the column Superdex 200 10/300 GL. The protein
elution proﬁles were used to estimate the Stokes radius (Table 1), as described in Sec-
tion 2.4. The LbHsp90 (solid line), LbHsp90N (dashed line) and LbHsp90NM (dotted
line) are showed. The molecular masses of the standard proteins are indicated by arrows.
Inset: estimation of the LbHsp90, LbHsp90N and LbHsp90NM Stokes radii as a function of
the values of−(logKav)1/2. B) Sedimentation velocity AUC experiments were performed
with the LbHsp90 (ﬁlled circles) and LbHsp90NM(empty circles) using a range of concen-
trations from 150 μg/mL up to 1000 μg/mL solved in 25 mMTris–HCl (pH 7.5) containing
50 mM NaCl and 1 mM β-mercaptoethanol. The ﬁgure presents the c(S) distribution of
the experiment at 1000 μg/mL of both proteins. All sedimentation proﬁles presented
only one species, even at higher concentrations. Inset: dependence of s20,w as a function
of protein concentration, which yielded s020,w (Table 1). Altogether, the results indicate
that LbHsp90 is constituted by dimeric species of 162±3 kDa whereas LbHsp90NM be-
haved as a monomer of 66±1 kDa. The results also show the signiﬁcance of the
C-domain for LbHsp90 oligomerization. C) Analytical SEC experiments of LbHsp90 as a
function of protein concentration were performed in the buffer 40 mM HEPES (pH 7.5),
100 mM KCl using the column Superdex 200 10/300 GL. The elution proﬁle shows that
LbHsp90 at high concentration eluated as a simple peak. Ten and twenty times decrease
of the protein concentration moved the main peak to the highest ET values and caused a
separation into two peaks. Inset: The ET observed was plotted against protein concentra-
tion and ﬁtted by the Eq. 3. The KD observed for LbHsp90 dissociation process was 80±
10 nM.Altogether, these results pointed out that LbHsp90 is a dimeric protein
and has an elongated shape in solution, whereas LbHsp90NM and
LbHsp90N are monomers with a less elongated shape than LbHsp90.
Also, these results showed the C-terminal of LbHsp90 as an important
region for dimerization, as observed in previous studies [21,22], and
the LbHsp90 dissociates into monomers in a nanomolar range.3.4. LbHsp90 chaperone activity
It was described that Hsp90 is able to bind model proteins, such as
citrate synthase and rhodanese, and protect them from aggregation
[43,46]. To verify if LbHsp90 has chaperone activity as well as its do-
mains are also able to prevent protein aggregation, we carried out ex-
periments using CS as a temperature-induced protein aggregation
model. Fig. 4A shows that LbHsp90 protected the CS from aggregation
in a dose-dependent way and even in a substoichiometric concentra-
tion (ratio CS:LbHsp90 of 8:1), displaying a potent chaperone activity.
As control, the incubation of CS with BSA did not show any protection
of CS aggregation and only LbHsp90, LbHsp90NM or LbHsp90N did
not aggregate (data not shown).
In addition to these data, the ability of the isolated domains of
LbHsp90 to prevent CS aggregation was also tested (Fig. 4B). Both
LbHsp90NM and LbHsp90N presented chaperone activity, which
corroborates with previous studies [46]. In spite of both LbHsp90 de-
letion variants also prevented CS aggregation in a dose-dependent
way, LbHsp90N protected CS from aggregation to a lower extent
than LbHsp90NM, which in turn protected less than the full length
protein. However, LbHsp90N showed less thermal stability than
LbHsp90 and LbHsp90NM, as shown by differential scanning calorime-
try and circular dichroism experiments (Supplementary material).
LbHsp90N presented a temperature of midpoint unfolding transition
at 45.6 °C while the two other proteins showed that the value centered
at 48.6 °C. These data indicate that the smaller chaperone activity of
LbHsp90N could be, at least in part, due to its lower thermal stability.
Besides, LbHsp90 and LbHsp90NMpresented the same thermal stability
proﬁle, which led us to the conclusion that LbHsp90NMhas lower chap-
erone activity than LbHsp90. To conﬁrm the differences observed for
LbHsp90N, we performed the prevention aggregation experiments of
MDH at 40 °C (Fig. 4C), which guarantee the structural stability of
LbHsp90N variant. In spite of the less speciﬁcity, LbHsp90 and deletion
variants protected MDH from thermal-induced aggregation. These re-
sults are in agreement with those observed for CS aggregation preven-
tion experiments (Fig. 4B), even though the aforementioned stability
of the LbHsp90N at 45 °C.
Fig. 4. Analysis of the ability of LbHsp90 in protein aggregation prevention. The chap-
erone activity of the proteins was assayed using the CS (0.8 μM) and MDH (1 μM) as
model substrates. The thermal-induced CS and MDH aggregation was followed by
light scattering at 320 nm, at 45 °C and 40 °C, respectively, for 60 min. A) Investigation
of LbHsp90 chaperone activity at various concentrations. The results showed that
LbHsp90 efﬁciently prevented CS aggregation, even in substoichiometric concentra-
tions. B) The LbHsp90N and LbHsp90NM were able to prevent CS aggregation, but in
a lower extent than LbHsp90. These results suggest that LbHsp90 possesses substrate
binding sites distributed along its structure and that its chaperone activity is indepen-
dent either of ATP and its dimeric state. C) The LbHsp90, LbHsp90NM and LbHsp90N
prevented the MDH aggregation, but with less efﬁciency than observed for CS, which
could indicate different substrate speciﬁcities for LbHsp90. Altogether, these results
also suggest that LbHsp90, LbHsp90NM and LbHsp90N possess substrate binding
sites distributed along the protein structure in a length-dependent manner.
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their ability to prevent protein aggregation could be explained by the
decrease of the substrate binding sites concomitant with the length of
the protein constructions and/or the loss of the dimeric structure of
LbHsp90. The full length protein is a dimer and presents more sites
for substrate binding than LbHsp90NM and the same can be conclud-
ed when comparing LbHsp90NM with LbHsp90N.
Altogether, these results revealed that LbHsp90 presents multiple
substrate binding sites distributed along the protein and its chaperone
activity is not exclusive for the LbHsp90 dimer. Moreover, the LbHsp90
chaperone activity is not ATP-dependent, since the experiments were
carried out in the absence of ATP and the isolated domains, which do
not have detectable ATPase activity (see below, Section 3.6.), were also
able to prevent protein aggregation.Fig. 5. Analysis of LbHsp90, LbHsp90N and LbHsp90NM interactions with ligands by
ﬂuorescence. The interaction of LbHsp90 and its deleting domains with ligands were
investigated by ﬂuorescence using the N-domain W147 as a probe. All data obtained
by ﬂuorescence were acquired at 20 °C, corrected for inner ﬁlter effects and treated
using the one binding site model, as described in Section 2.5. A) The curves represent
the suppression signal ((F−F0)/ Imax) as a function of ATP concentration in the absence
of Mg2+. The KD-values obtained for protein–ligand interactions are shown in the
Table 2. Similar curves were obtained with other ligands (data not shown). B) Satura-
tion curves of the interaction of LbHsp90, LbHsp90N and LbHsp90NM with GA. The
curves clearly present different slopes suggesting that the proteins interact with GA
through different KD. The data suggest that the afﬁnity interaction with GA present
the following order: LbHsp90N>LbHsp90NM>LbHsp90, as presented in Table 2.
Table 2
Comparison of the values of KD determined from the interaction between LbHsp90,
LbHsp90N and LbHsp90NM, with the nucleotides ATP, ADP, and AMPPNP in the pres-
ence and absence of MgCl2, at 20 °C.
Ligand KD (μM)
LbHsp90 LbHsp90NM LbHsp90N
ATP 120±20 200±30 240±30
ATP+MgCl2 140±30 180±20 180±20
ADP 160±10 160±20 130±10
ADP+MgCl2 130±10 120±10 90±10
AMP-PNP 150±10 160±20 180±30
AMPPNP+MgCl2 160±10 180±20 200±40
GAa 7.6±0.2 4.0±0.9 1.8±0.3
a Experiments performed in the presence of 2% DMSO (V/V).
Fig. 6. Study of LbHsp90 and LbHsp90NM ATPase activity by enzyme kinetics. A)
LbHsp90 (2 μM) and LbHsp90NM (2 μM) were incubated with ATP (0–5 mM) during
90 min at 37 °C, and the Pi released from ATP hydrolysis was quantiﬁed. The data
were treated with a Michaelis–Menten ﬁtting for achievement of kinetic parameters,
which were a kcat of 0.320 min−1 and a Km value of 430±30 μM. In contrast with
the wild type protein, the LbHsp90NM ATPase activity was negligible indicating that
the C-terminal dimerization is essential for the LbHsp90ATPase activity. B) The
LbHsp90 was previously incubated with increasing concentrations of GA (from 0 up
to 50 μM) for 30 min and the ATP was added at 3 mM. After incubation at 37 °C, the
Pi released was quantiﬁed. In order to obtain the IC50 for GA inhibition of LbHsp90,
the data was treated by a dose–response model and the value of IC50 was 0.7±
0.2 μM. Since the GA inhibition is competitive, the residual activity observed of about
20% could be related to a displacement of GA-LbHsp90 interaction by the high ATP
concentration.
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As argued above, LbHsp90 has ﬁve tryptophans and we used their
ﬂuorescence signal to analyze the tertiary structure of all proteins.
The ﬂuorescence spectra showed all recombinant proteins folded
and the single tryptophan residue in the N-domain is buried in the
protein structure (Fig. 2C). W147 was used, as a ﬂuorescent probe,
to monitor the interaction with the ligands of the nucleotide binding
site. The proteins were incubated with ATP, ADP, and AMPPNP, at
20 °C, in the presence and absence of 5 mM MgCl2, and the ﬂuores-
cence emission was recorded. The experiments did not show changes
in the λmax induced by the presence of ligands (data not shown), but
the interaction resulted in ﬂuorescence suppression allowing to ob-
tain the KD through the F−F0/ Imax as a function of the nucleotide
concentration. Fig. 5A depicts the saturation curves of LbHsp90,
LbHsp90NM and LbHsp90N with ATP, as an example. Similar proﬁles
were obtained for ADP and AMPPNP (data not shown). Table 2 shows
the KD obtained for proteins and adenosine ligands, suggesting that
similar values of 150 μM were observed in the experimental condi-
tions tested. The interaction of LbHsp90N with ADP in the presence
of MgCl2 was the exception since it presented a lower KD (90 μM)
than in the other conditions tested (Table 2). The higher afﬁnity for
ADP in the presence of Mg2+ ions was also reported for human and
yeast Hsp90 [24,41], since divalent ions like Mg2+ were found in
complexes with ADP in crystallographic yeast N-domain [44]. Our re-
sults suggested that LbHsp90 afﬁnity for ATP (KD=120±20 μM) was
twice than that showed for hHsp90, which was obtained in similar
experimental conditions, considering a KD about 240±14 μM at
25 °C [41]. On the other hand, the N-domain of yHsp90 showed a
KD of 132±47 μM for ATP [44] obtained by isothermal titration calo-
rimetry (ITC), similar to the value observed for LbHsp90. Considering
the importance of these data, their comparisons must be performed
with care since the Hsp90 afﬁnity with adenosine ligands depends
on the experimental conditions such as pH, temperature and ionic
strength [24,41,47].
The interaction of GA with proteins in this study revealed differ-
ences in the KD of the proteins. Fig. 5B shows that GA induced different
suppression effects on the different proteins tested, which yielded dif-
ferent values of KD among the proteins and GA (Table 2). LbHsp90N
showed higher afﬁnity for GA, which was followed by LbHsp90NM
and LbHsp90. Roe et al. [29] also reported that N-domain of yHsp90
has a higher afﬁnity for GA than yHsp90 does. These results suggest
that the interactions of the N-domain with the rest of the protein
and/or the conformational changes involved in the LbHsp90 cycle
are important to GA interaction. Since LbHsp90N did not have the in-
terference of M-domain and/or C-domain present in the constructs
LbHsp90 and LbHsp90NM, it has a higher afﬁnity. This result is quite
interesting for developing inhibitors using Hsp90 as a target, since
many crystal structures of the N-domain–GA complexes are used as a
model for interactionwith GA, but Hsp90 is the real target for inhibitors.The dissociation constant observed for LbHsp90–GA (KD=7.6±
0.2 μM) was nearly ﬁfteen times less than LbHsp90-ATP (KD=120±
20 μM) and was in the same range to those reported for P. falciparum
Hsp90 (1.05 μM) [5] and yHsp90 (KD=1.2 μM) [29]. The GA binds in
the N-domain of Hsp90 in a tapered pocket that is hydrophobic and
polar [12]. At the hydrophobic bottom of the pocket there is an impor-
tant charged amino acid (Asp93 in hHsp90) thatmakes direct hydrogen
bound with GA and it is conserved in various species [12]. It was also
found that the pocket where GA binds is the same as the nucleotides
and GA could be an ATP/ADP mimetic that competes with ATP for the
binding to the nucleotide-binding domain, hence forming amore stable
complex [44]. This observation agrees with our results that showed GA
has greater afﬁnity for LbHsp90 than ATP. Therefore, our results are
quite interesting considering the use of GA and analogues as a compet-
itive Hsp90 inhibitor.
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The ATPase activity is critical for Hsp90 function in vivo requiring the
complete protein [13–15]. The known slow Hsp90 ATPase activity sug-
gests that it is coupled to conformational rearrangements of the Hsp90
functional cycle [9,25]. However, the ATPase activity of Hsp90 of the dif-
ferent organisms has different rates [11,17,41,48], suggesting that Hsp90
orthologs may have a slightly different action cycle. The LbHsp90 ATPase
activity was studied by analyzing the concentration of Pi released
from the ATP hydrolysis per minute as a function of the ATP concentra-
tion. The kinetic parameters were obtained by a Michaelis–Menten
non-linear ﬁtting of the ATPase activity rate (Fig. 6A). As reported for
Hsp90 orthologs, in spite of the dimeric structure of Hsp90 and depen-
dence on this oligomeric state [17,24,41,48], no cooperativity signal was
observed in the LbHsp90 ATPase activity suggesting that the ATPhydro-
lysis kinetics is an independent Michaelis–Menten catalysis in each
subunit of the LbHsp90 dimer.
The kcat-value observed was 0.320 min−1, suggesting that LbHsp90
has a low ATPase activity such as the Hsp90 of chicken, yeast, human,
and E. coli [13,15,17,24,41]. This low kcat-value is compatible with the
ATPase mechanism that includes several conformational changes and
a slow hydrolysis rate [9,22,25,41]. The nucleotide binding triggers con-
formational changes involving the ATP trapping to the nucleotide bind-
ing pocket, the approach of the N-domains of the Hsp90 dimer, and the
ATP hydrolysis as the rate-limiting step of the reaction [22,24,25,41].
This process involves large conformational changes of Hsp90 which
assumes a “tense” state when ATP binds to the N-domains triggering
their association, and a “relaxed” state with the ATP hydrolysis, ADP
and N-domain dissociations [11,15]. The Km-value observed for
LbHsp90 and ATP (430±30 μM) was also in the range reported for
Hsp90 orthologs with different methodologies [5,14,17,41], suggesting
a similar mechanism of interaction between LbHsp90 and ATP, as ar-
gued above.
In order to investigate the ATPase activity of LbHsp90, the capacity of
LbHsp90NMtohydrolyzeATPwas also analyzed. The results indicate that
besides LbHsp90NM having the nucleotide binding site, it was not possi-
ble to detect a substantial ATPase activity (Fig. 6A). The non-detectable
ATPase activity of LbHsp90NM suggests the importance of the complete
protein to the ATPase activity, since LbHsp90NM is a monomer and can-
not undergo all conformational changes required to hydrolyze ATP. Also,
LbHsp90NM lacks the C-domain entirely and does not have some regions
thatmay be important to ATPase activity even in themonomeric state, as
observed for chicken [17], yeast [22] and humanHsp90 [41], inwhich the
NM constructions have tenfold lower catalytic constant than the native
ones. Likewise, it was shown that a full-length Hsp90 is required for the
ATP hydrolysis, and is essential for in vivo function together with the
ATP binding [14]. Furthermore, the N-domain dimerization is required
for ATP hydrolysis and in vivo function [22,48,49]. Mutants that lack re-
gions from the C-domain showed signiﬁcantly reduced ATPase activity
in comparison with the wild-type protein [15,22,24]. In addition, there
are regions along theM-domain andC-domain of Hsp90 that are relevant
to ATP hydrolysis since they are related to the ATP commitment by trap-
ping it [24]. On the other hand, mutants that stabilize the N-domain di-
merization present higher ATPase activity than the wild-type protein
[48].
The interaction with GA leads Hsp90 to a degradation mode instead
of its refolding function, inhibiting it, hence the substrates are subjected
to proteasome degradation [11,28,30]. To investigate the effects of
LbHsp90–GA interaction, the LbHsp90 ATPase activity in the presence
of GA was investigated and it was found that GA was able to inhibit
the LbHsp90 ATPase activity, with an IC50 of 0.7±0.2 μM(Fig. 6B). A re-
sidual ATPase activity of about 20% was observed for LbHsp90 and was
related to a displacement of GA from the ATP-binding pocket for ATP, as
the inhibition mechanism is competitive and the ATP concentration
used was much higher than those for GA. Residual ATPase activity of
10–20% was also reported for yHsp90 ATPase inhibition assays byboth GA and radicicol [13,29], which were attributed to copurifying
ATPases, a possibility we cannot discard in our experiments.
In comparisonwith the P. falciparumHsp90, LbHsp90 seems to be less
sensitive to GA than PfHsp90, since the IC50 described in the literature
was 207 nM [5], whereas the IC50 for hHsp90 (702 nM) shown in the
same work was similar to LbHsp90 [5]. When compared with yHsp90
(IC50=2–5 μM) [13,29], LbHsp90 is more sensitive to GA inhibition.
However, these comparisons are limited since the experimental condi-
tions and methods are different, but still valid considering that GA may
be a competitive inhibitor used togetherwith other drugs to combat par-
asite growth such as P. falciparum [35]. To date, there are various Hsp90
inhibitors, including GA and derivatives, and other recent inhibitors that
are being studied in order to ﬁndmore effective therapies [31,32]. In the
case of Hsp90 as a drug target against protozoan, further studies are
needed to determine the mechanism of interaction of protozoa Hsp90
with GA and analogues, as well as the interaction with other inhibitors.
These studies can lead to the identiﬁcation of a selective inhibitor against
protozoa Hsp90. On the other hand, it is also important to understand
the effect of the LbHsp90 co-chaperones in its action cycle and identify
the posttranslational modiﬁcations, two features that greatly inﬂuence
the Hsp90 activity [10,11].
4. Conclusions
The aim of this studywas to produce and characterize some structur-
al and functional aspects of the Hsp90 of the protozoa L. braziliensis, one
of the causative agents of the neglected disease called Leishmaniasis
[1,2]. Several studies focusing on the structure–function relationship of
Hsp90 have been published mainly for human and yeast orthologs,
since hHsp90 is a target for cancer therapy and yHsp90 is an established
model of study. Recently, Hsp90 has been also pointed as a target against
protozoa diseases [4].
Here, we report the production of the recombinant proteins
LbHsp90, LbHsp90N, and LbHsp90NM in the folded and functional
state. In solution, LbHsp90N and LbHsp90NM behaved as elongated
monomers while the entire protein was an elongated dimer, which
reﬂects the importance of the C-domain for LbHsp90 dimerization.
We also observed that LbHsp90 dimer dissociates into monomers
with KD of 80 nM. LbHsp90was able to prevent CS andMDHaggregation
with potent chaperone activity whereas LbHsp90NM and LbHsp90N
showed lower activity, which could be due to the presence of more
sites in LbHsp90 when compared with its isolated domains. The interac-
tion between LbHsp90 with adenosine ligands resulted in KD-values of
around of 150 μM, whereas the KD for GA–LbHsp90 interaction was
more than ﬁfteen times smaller. Furthermore, the greater GA afﬁnity
was found for LbHsp90N, suggesting that the presence of other domains
or the dynamics of Hsp90 may interfere in this interaction.
It was demonstrated that LbHsp90 has a low ATPase activity as
shown in Hsp90 orthologs. The LbHsp90NM has negligible ATPase activ-
ity even with the presence of the nucleotide binding site and the pres-
ence of the catalytic Arg380 in the M-domain, attesting the importance
of the protein as a dimer for its function, which involves the N-domain
dimerization and conformational changes between the protomers. Fur-
thermore, we observed that GA inhibited the LbHsp90 ATPase activity
in the same range of IC50 of that found for other Hsp90 orthologs.
In summary, our work showed that LbHsp90 presents structural and
functional features that are similar to the well studied Hsp90s. We be-
lieve that this study sheds light on the Hsp90molecular chaperonema-
chinery in protozoa, but further studies are needed to understand in
details how protozoa Hsp90 works. Moreover, we are investigating
the co-chaperones of LbHsp90 in order to elucidate how these proteins
modulate the LbHsp90 activity. We have identiﬁed and successfully
produced the recombinant Aha1, Hop and p23 of L. braziliensis that
will yield deeper information about Hsp90molecular chaperone system
of protozoan. All these studies may help evaluate if Hsp90 is a good tar-
get for drug development against protozoa diseases.
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